Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

Europe plans further antibiotic shortage countermeasures

January 24, 2023 Medical Communications

With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to …
News

WHO issues a “call to action” after cough syrup deaths

January 24, 2023 Medical Communications

WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, …
News

First Indian intranasal COVID-19 vaccine about to launch

January 23, 2023 Medical Communications

Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ …
News

FDA awards CardioRenal Systems Breakthrough Device Designation for RenalGuard Therapy

January 23, 2023 Medical Communications

The FDA has granted Breakthrough Device Designation for US-based medical technology company CardioRenal for their RenalGuard Therapy device, used to …
News

Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs

January 20, 2023 Medical Communications

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found …
News

Alnylam and PTC Therapeutics’ rare disease drugs given backing by NICE

January 20, 2023 Medical Communications

Alnylam’s Amvuttra and PTC Therapeutics’ Translarna will be available to patients through the NHS after being backed by NICE, despite …
News

Abbott secures FDA approval for Navitor TAVI device

January 19, 2023 Medical Communications

US-based medical device firm Abbott has secured FDA approval for Navitor to treat people with aortic stenosis who are at …
News

Johnson & Johnson cuts trial for its HIV vaccine following disappointing data

January 19, 2023 Medical Communications

Johnson & Johnson (J&J) has announced that it has ended its clinical trial for its experimental HIV vaccine, following disappointing …
News

AI tool to improve blood sugar management in type 1 diabetes patients

January 18, 2023 Medical Communications

A new app, designed by researchers at Oregon Health & Science University (OSHU), uses artificial intelligence (AI) to assess blood …
News

Cambridge’s Experimental Cancer Medicine Centre to receive funding for clinical trials

January 18, 2023 Medical Communications

The Experimental Cancer Medicine Centre (ECMC) in Cambridge is one of a selection of organisations to receive a share of …
News

UCL to begin new trial to assess cough medicine’s impact on Parkinson’s disease

January 17, 2023 Medical Communications

Researchers led by a team at University College London (UCL) have began researching the impacts of ambroxol, a common ingredient …
News

Thermo Fisher to become founding sponsor of Momentum Labs

January 17, 2023 Medical Communications

Thermo Fisher Scientific has announced that it has become a founding sponsor of Momentum Labs in Alachua, Florida, US. The …
News

Indonesia begins hearing class-action lawsuit after children’s deaths from cough syrup

January 17, 2023 Medical Communications

An Indonesian court has begun proceedings to hear a class-action lawsuit against health and finance ministries, the drugs regulator and …
News

Boehringer Ingelheim and 3T Biosciences form $268m partnership to develop next-generation cancer immunotherapies

January 16, 2023 Medical Communications

Germany-based Boehringer Ingelheim and US company 3T Biosciences have entered into a strategic collaboration and licensing agreement to research and …
News

Eli Lilly and AbbVie leave UK VPAS; blow to UK pharma industry

January 16, 2023 Medical Communications

Eli Lilly and AbbVie have announced their departure from the voluntary scheme for branded medicines pricing and access (VPAS), causing …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026